前收市價 | 20.10 |
開市 | 8.45 |
買盤 | 0.00 |
賣出價 | 0.00 |
拍板 | 590.00 |
到期日 | 2024-07-12 |
今日波幅 | 8.45 - 20.10 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 2 |
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.
In the most recent trading session, McKesson (MCK) closed at $603.24, indicating a +0.05% shift from the previous trading day.
The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients improved treatment options for prostate cancer.